KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Return on Equity (2016 - 2025)

Bausch Health Companies' Return on Equity history spans 16 years, with the latest figure at 1.28% for Q4 2025.

  • For Q4 2025, Return on Equity fell 137.0% year-over-year to 1.28%; the TTM value through Dec 2025 reached 1.28%, down 137.0%, while the annual FY2025 figure was 0.27%, 33.0% down from the prior year.
  • Return on Equity for Q4 2025 was 1.28% at Bausch Health Companies, up from 1.54% in the prior quarter.
  • Across five years, Return on Equity topped out at 11.09% in Q4 2021 and bottomed at 54.11% in Q3 2023.
  • The 5-year median for Return on Equity is 0.45% (2022), against an average of 1.8%.
  • The largest annual shift saw Return on Equity tumbled -5490bps in 2023 before it skyrocketed 5504bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 11.09% in 2021, then crashed by -106bps to 0.61% in 2022, then soared by 259bps to 0.97% in 2023, then tumbled by -90bps to 0.09% in 2024, then tumbled by -1448bps to 1.28% in 2025.
  • Per Business Quant, the three most recent readings for BHC's Return on Equity are 1.28% (Q4 2025), 1.54% (Q3 2025), and 1.03% (Q2 2025).